DNase I levels and disease outcome in JIA patients treated with etanercept
نویسندگان
چکیده
Methods The study was performed in 25 JIA patients who donated paired serum samples prior and one year after continous etanercept therapy. Basic clinical data (six core set variables defined in ACR PEDI outcome score) were recorded along with alkalyne DNase I serum levels using the method where acid soluble nucleotides are determined spectrophotometrically at 260 nm. Treatment schedule of etanercept was 0,4mg/kg body weight subcutaneously twice weekly.
منابع مشابه
DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
Methods The study was performed in 25 JIA patients who donated paired serum samples prior and one year after continous etanercept therapy. Basic clinical data (six core set variables defined in ACR PEDI outcome score) were recorded along with alkalyne DnaseI serum levels using the method where acid soluble nucleotides are determined spectrophotometrically at 260 nm. Treatment schedule of etaner...
متن کاملLong-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO.
OBJECTIVE To assess the outcome of adult patients with JIA who received etanercept (ETA) during childhood. METHODS JuMBO (Juvenile arthritis MTX/Biologics long-term Observation) is an ongoing prospective cohort study. It follows adult JIA patients who were formerly included in the national JIA biologic register. In JuMBO, clinical status, therapy and the occurrence of adverse events are docum...
متن کاملEfficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
OBJECTIVES To evaluate the influence of low-dose MTX and etanercept treatment on efficacy of measles, mumps and rubella (MMR) revaccination in children with juvenile idiopathic arthritis. METHODS A prospective nested case-control study was performed to investigate markers of MMR revaccination induced humoral and cell-mediated immunity in 15 patients with juvenile idiopathic arthritis (ages 6-...
متن کاملSalivary antioxidants and metalloproteinases in juvenile idiopathic arthritis.
Juvenile idiopathic arthritis (JIA) is the most common autoimmune inflammatory disease in children; joint inflammation is the hallmark of the disease. Thirty-five children with JIA were studied, of whom 26 had active disease and 14 were receiving anti-TNF therapy (5 with Infliximab, 9 with Etanercept). Sixteen healthy controls also were studied. Saliva samples were obtained for analysis of anti...
متن کاملSafety and efficacy of varicella vaccination in children with JIA treated with biologic therapy
Methods We designed a prospective study on a long term follow up. Five patients with JIA (median age 5, range 3,5-7 years), treated also with biologic therapy (2 etanercept, 2 tocilizumab, 1 infliksimab), received 2 doses of varicella vaccine. One patient treated with etanercept received the first dose before starting etanercept, others received both doses on biologic therapy. Before vaccinatio...
متن کامل